Observational studyThrombosis and haemostasis2018
Rationale, Design and Methodology of the Computerized Registry of Patients with Venous Thromboembolism (RIETE).
Observational study in Thrombosis and haemostasis, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
83 citing papers in PubMed, 1 synthesis or guideline pooled it, 211 citations in OpenAlex.
- Venous thromboembolism in in-hospital cirrhotic patients: A systematic review.Frontiers in medicine · 2022Pooled it
- Early outcomes after venous thromboembolism in Hispanic and non-Hispanic patients: insights from the Registro Informatizado de Enfermedad TromboEmbólica Registry.Research and practice in thrombosis and haemostasis · 2026Observational
- Global burden of venous thromboembolism: incidence and outcome estimates of deep-vein thrombosis and pulmonary embolism.Nature reviews. Cardiology · 2026Review
- Venous Thromboembolism in Severe Renal Insufficiency: 20 Years of Contemporary Management and Clinical Outcomes.JACC. Advances · 2026Article
- Venous thromboembolism in women on estrogen therapy: presentation, management, and outcomes in the RIETE registry.Blood advances · 2026Article
- Next-Generation Cardiovascular Imaging in Precision Medicine: Integrating Functional Imaging, Artificial Intelligence, Biomarkers, and Personalized Risk Stratification.Diagnostics (Basel, Switzerland) · 2026Review
- Pleural effusion as a mortality predictor for acute pulmonary embolism.Research and practice in thrombosis and haemostasis · 2026Article
- Time Trends in Cause-Specific Mortality in Patients with Pulmonary Embolism Aged 50 Years and Older.Thrombosis and haemostasis · 2026Article
- Upper Extremity Deep Vein Thrombosis in Cancer Patients: Clinical Course by Cancer Site.JACC. CardioOncology · 2026Article
- Outcomes in venous thromboembolism with retained vs removed inferior vena cava filters: an analysis from the Registro Informatizado de Enfermedad TromboEmbólica.Research and practice in thrombosis and haemostasis · 2026Article
- Oxygen saturation and mortality for acute pulmonary embolism: multinational retrospective cohort study.EClinicalMedicine · 2026Article
- Characteristics and outcomes of acute pulmonary embolism among patients with polyvascular, single-vascular or no atherosclerotic disease: insights from RIETE.Clinical research in cardiology : official journal of the German Cardiac Society · 2026Article
- Evaluation of microbial-derived metabolites in patients with acute pulmonary embolism: findings from the MICTEP study.ERJ open research · 2025Article
- Comparative safety of enoxaparin versus other low-molecular-weight heparins in cancer-associated venous thromboembolism: a real-world cohort study from RIETE.Research and practice in thrombosis and haemostasis · 2025Article
- Influence of patient's weight and body mass index on presentation, time of onset, and impact of postoperative venous thromboembolism (RIETE registry).Journal of thrombosis and thrombolysis · 2025Observational
- A machine learning approach to identify patients at risk for long-term consequences after pulmonary embolism.Scientific reports · 2025Article
- Low-Density Lipoprotein Cholesterol Levels and Bleeding Risk in Venous Thromboembolism.JAMA network open · 2025Article
- Failure rate of the pulmonary embolism rule-out criteria rule for adults 35 years or younger: Findings from the RIETE Registry.Academic emergency medicine : official journal of the Society for Academic Emergency Medicine · 2025Article
- Lower early mortality and risk prediction improvement of obesity after acute pulmonary embolism: results from a multicenter cohort analysis with external validation.Research and practice in thrombosis and haemostasis · 2025Article
- Research progress of artificial intelligence and machine learning in pulmonary embolism.Frontiers in medicine · 2025Review
23 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 11 institutions in 5 countries.
Funding
Abstract
Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is a preventable cause of in-hospital death, and one of the most prevalent vascular diseases. There is a lack of knowledge with regards to contemporary presentation, management and outcomes of patients with VTE. Many clinically important subgroups (including the elderly, those with recent bleeding and pregnant patients) have been under-represented in clinical trials. Furthermore, design of clinical trials is challenging in some scenarios, such as in those with hemodynamically unstable PE. RIETE (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.